Abbonarsi

Novel endoscopic technique for trisegment drainage in patients with unresectable hilar malignant biliary strictures (with video) - 21/08/20

Doi : 10.1016/j.gie.2020.03.003 
Yuta Maruki, MD 1, Susumu Hijioka, MD 1, ⁎, Shih Yea Sylvia Wu, MD 2, Akihiro Ohba, MD 1, Yoshikuni Nagashio, MD 1, Shunsuke Kondo, MD 1, Chigusa Morizane, MD 1, Hideki Ueno, MD 1, Takuji Okusaka, MD 1, Yutaka Saito, MD 2
1 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan 
2 Department of Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan 

∗Reprint requests: Susumu Hijioka, MD, Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.Department of Hepatobiliary and Pancreatic OncologyNational Cancer Center Hospital5-1-1 TsukijiChuo-kuTokyoJapan

Abstract

Background and Aims

Three or more stents may be needed in patients with extensive stricturing in Bismuth type IIIa/IV hilar malignant strictures. Partial stent-in-stent (PSIS) deployment has been the primary intervention for hilar malignant biliary stricture (MBS). However, simultaneous side-by-side (SBS) stent placement has become feasible with the development of the <6F diameter stent delivery system. Our aim was to assess the efficacy and safety of a new hybrid method combining PSIS and SBS stent placement for trisegment biliary drainage.

Methods

This study included 17 consecutive patients with Bismuth IIIa or IV malignant strictures who underwent endoscopic drainage using the hybrid method. Diameters of the delivery stents were 5.4F (n = 10) and 5.7F (n = 7).

Results

The technical success rate was 82% (14/17), and the median length of procedures was 54 minutes. Two patients required predilatation for deployment of the third self-expandable metallic stent through the mesh of the first deployed stent. Two patients (12%) developed cholecystitis as early adverse events, and 1 patient (6%) developed liver abscess as a late adverse event. The time to recurrent biliary obstruction among those with successful initial trisegmental drainage was 189 days (95% confidence interval, 124-254).

Conclusions

The hybrid method for unresectable hilar MBS is an effective endoscopic drainage method, and the ease of these procedures is partly attributed to the thinner stent delivery system.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : MBS, PSIS, SBS, SEMS, TRBO


Mappa


 DISCLOSURE: All authors disclosed no financial relationships. This work was supported in part by The National Cancer Center Research and Development Fund 31-A-13 and JFE (The Japanese Foundation for Research and Promotion of Endoscopy) Grant.
 If you would like to chat with an author of this article, you may contact Dr Hijioka at rizasusu@gmail.com.


© 2020  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 92 - N° 3

P. 763-769 - settembre 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Surveillance for pathology associated with cancer on endoscopy (SPACE): criteria to identify high-risk gastric polyps in familial adenomatous polyposis
  • Gautam N. Mankaney, Michael Cruise, Shashank Sarvepalli, Amit Bhatt, Zubin Arora, Brian Baggot, Lisa Laguardia, Margaret O’Malley, James Church, Matthew Kalady, Carol A. Burke
| Articolo seguente Articolo seguente
  • The waterjet necrosectomy device for endoscopic management of pancreatic necrosis: design, development, and preclinical testing (with videos)
  • Patrick Yachimski, Claire A. Landewee, Federico Campisano, Pietro Valdastri, Keith L. Obstein

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.